Researchers look into new clinical trial design

Researchers from Princeton University, California Institute of Technology, Harvard School of Public Health and the University of Cambridge are currently testing a new trial design called “two-by-two,” which could potentially provide a better link to a patient’s...

Welcome Mary Anne Gfell to Pearl Pathways

Pearl Pathways is excited to announce the addition of Mary Anne Gfell to the team as a Clinical Research Advisor. Bringing over 15 years of experience in clinical research and quality compliance, Gfell is a key addition to the Pearl Pathways team. Prior to joining...

Could the Sunshine Act be the cause of decline in research funding?

According to a recent article in News-Medical.net, the Sunshine Act’s new Open Payments plan could potentially be the cause of a dramatic downfall in U.S. clinical research. Research conducted from the U.S. Open Payments database has shown that between 2013 and 2014,...

Positive results in clinical trials down to 8% in recent years

After implementing a new transparency program requiring sponsors to register their trial on Clinicaltrials.gov and identify study outcomes, it was found that only 8% of clinical trials report positive results. Clinical trials performed from 2000 to 2012 reported...

Can clinical trials really “fail”?

Every so often, clinical tries are said to ‘fail’, but can the trial actually fail? According to John Lechleiter, President and CEO of Eli Lilly and Company, “a clinical trial is a failure only if we can’t learn from it.” He believes that no matter how a clinical...